Originally published on LinkedIn. Novartis Pharmaceuticals is a Fair360, formerly DiversityInc Hall of Fame company.
Novartis Pharmaceuticals is accelerating its journey toward expanding access to medicines, improving health equity, and achieving a zero-carbon future. ESG is central to the Novartis strategy and is key to delivering long-term value to patients, providers, employees and other stakeholders.
To read more about Novartis’ progress toward its ESG targets, click here.
